Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

被引:1651
作者
Gnecchi, Massimiliano [1 ,3 ,4 ]
Zhang, Zhiping [1 ,2 ]
Ni, Aiguo [1 ,2 ]
Dzau, Victor J. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Mandel Ctr Hypertens Res, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Cardiovasc, Dept Med, Durham, NC 27710 USA
[3] Fdn IRCCS Policlin San Matteo, Lab Expt Cardiol Cell & Mol, Div Cardiol, Pavia, Italy
[4] Univ Pavia, Dept Heart Blood & Lung, I-27100 Pavia, Italy
关键词
adult stem cells; paracrine signaling; cytoprotection; neovascularization; regeneration;
D O I
10.1161/CIRCRESAHA.108.176826
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Animal and preliminary human studies of adult cell therapy following acute myocardial infarction have shown an overall improvement of cardiac function. Myocardial and vascular regeneration have been initially proposed as mechanisms of stem cell action. However, in many cases, the frequency of stem cell engraftment and the number of newly generated cardiomyocytes and vascular cells, either by transdifferentiation or cell fusion, appear too low to explain the significant cardiac improvement described. Accordingly, we and others have advanced an alternative hypothesis: the transplanted stem cells release soluble factors that, acting in a paracrine fashion, contribute to cardiac repair and regeneration. Indeed, cytokines and growth factors can induce cytoprotection and neovascularization. It has also been postulated that paracrine factors may mediate endogenous regeneration via activation of resident cardiac stem cells. Furthermore, cardiac remodeling, contractility, and metabolism may also be influenced in a paracrine fashion. This article reviews the potential paracrine mechanisms involved in adult stem cell signaling and therapy. (Circ Res. 2008; 103: 1204-1219.)
引用
收藏
页码:1204 / 1219
页数:16
相关论文
共 95 条
[41]   Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells [J].
Kong, D ;
Melo, LG ;
Mangi, AA ;
Zhang, L ;
Lopez-Ilasaca, M ;
Perrella, MA ;
Liew, CC ;
Pratt, RE ;
Dzau, VJ .
CIRCULATION, 2004, 109 (14) :1769-1775
[42]   Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans [J].
Kubal, Chandrashekhar ;
Sheth, Kamlesh ;
Nadal-Ginard, Bernardo ;
Galinanes, Manuel .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (05) :1112-1118
[43]   Cardiac stem cells and mechanisms of myocardial regeneration [J].
Leri, A ;
Kajstura, J ;
Anversa, P .
PHYSIOLOGICAL REVIEWS, 2005, 85 (04) :1373-1416
[44]   Bc1-2 engineered MSCs inhibited apoptosis and improved heart function [J].
Li, Wenzhong ;
Ma, Nan ;
Ong, Lee-Lee ;
Nesselmann, Catharina ;
Klopsch, Christian ;
Ladilov, Yury ;
Furlani, Dario ;
Piechaczek, Christoph ;
Moebius, Jeannette M. ;
Luetzow, Karola ;
Lendlein, Andreas ;
Stamm, Christof ;
Li, Ren-Ke ;
Steinhoff, Gustav .
STEM CELLS, 2007, 25 (08) :2118-2127
[45]   The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model [J].
Lim, Sang Yup ;
Kim, Yong Sook ;
Ahn, Youngkeun ;
Jeong, Myung Ho ;
Hong, Moon Hwa ;
Joo, Soo Yeon ;
Nam, Kwang Il ;
Cho, Jeong Gwan ;
Kang, Peter M. ;
Park, Jong Chun .
CARDIOVASCULAR RESEARCH, 2006, 70 (03) :530-542
[46]   Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function [J].
Linke, A ;
Müller, P ;
Nurzynska, D ;
Casarsa, C ;
Torella, D ;
Nascimbene, A ;
Castaldo, C ;
Cascapera, S ;
Böhm, M ;
Quaini, F ;
Urbanek, K ;
Leri, A ;
Hintze, TH ;
Kajstura, J ;
Anversa, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (25) :8966-8971
[47]  
Malik Dhirendra Kumar, 2007, Current Drug Delivery, V4, P141
[48]   Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts [J].
Mangi, AA ;
Noiseux, N ;
Kong, DL ;
He, HM ;
Rezvani, M ;
Ingwall, JS ;
Dzau, VJ .
NATURE MEDICINE, 2003, 9 (09) :1195-1201
[49]   Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction [J].
Matsumoto, R ;
Omura, T ;
Yoshiyama, M ;
Hayashi, T ;
Inamoto, S ;
Koh, KR ;
Ohta, K ;
Izumi, Y ;
Nakamura, Y ;
Akioka, K ;
Kitaura, Y ;
Takeuchi, K ;
Yoshikawa, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) :1168-1173
[50]   Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium - Reasons for cautious optimism [J].
Melo, LG ;
Pachori, AS ;
Kong, D ;
Gnecchi, M ;
Wang, K ;
Pratt, RE ;
Dzau, VJ .
CIRCULATION, 2004, 109 (20) :2386-2393